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ABSTRACT 
 The purpose of this Practice Improvement Project was to promote evidence-based 
practice in caring for children ages 4-18 with Attention Deficit Hyperactivity Disorder (ADHD) 
in the family practice setting.  The American Academy of Pediatric Clinical Practice Guidelines 
(CPG) and the Diagnostic and Statistical Manual of Mental Health Conditions, 5th Ed. (DSM-V) 
diagnostic criteria for ADHD were embedded in the electronic health record (EHR) in the form 
of an evaluation tool/template to guide the Primary Care Providers (PCPs) in documenting 
evidence-based practice in the assessment, diagnosis and treatment of ADHD.  Primary 
stakeholders are PCPs of Riverview Clinic who care for children with ADHD.  
  Neuman’s System Theoretical framework was used assuring a comprehensive holistic 
approach to caring for children with ADHD.  The logic model was applied to direct project 
process while providing a framework for project evaluation.  A focused forum was held to 
educate PCPs on the American Academy of Pediatrics (AAP) CPG and the DSM-V ADHD 
diagnostic criteria.  PCPs were introduced to the tool with instruction on use.  Six weeks post 
launching, a retrospective chart audit was done to evaluate for the presence of evidence based-
practice documentation with the evaluation tool/template versus without.   
When utilized, the evaluation tool/template demonstrates a higher rate of documentation 
supportive of evidence-based practice.  The tool enhances provider’s comfort level in caring for 
children with ADHD while promoting optimal quality outcome for the child.  Project outcome 
suggests the tool be used by PCPs in documenting evidence-based practice.  Key words: ADHD, 
children, management, EHR, template, co-morbid conditions, and clinical practice guidelines.   
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CHAPTER ONE 
Introduction 
 Attention deficit hyperactivity disorder (ADHD) is the most common neurobehavioral 
disorder of childhood.  ADHD is also among the most prevalent chronic health conditions 
affecting school- aged children.  Inattention, hyperactivity, and impulsivity are the core 
symptoms.  The onset of symptoms occurs in early childhood and often continues into 
adolescence and adulthood.  School difficulties, academic underachievement, troublesome 
interpersonal relationships, and low self-esteem are often associated with this disorder (Barkley, 
2006; Franks-Briggs, 2011; Hines, King, & Curry, 2012; Rader, McCauley & Callen, 2009; 
Xenitidis, Maltezos & Pitts, 2011).    
 The diagnosis of ADHD is primarily a subjective process and because of this, the 
evaluator’s perception plays a vital role in the outcome of the evaluation.  Many question the 
validity of this disorder as a result of the heightened awareness of its prevalence.  Other 
compounding issues include the clinician’s failure to conduct a comprehensive diagnostic 
evaluation, or neglect in utilizing the Diagnostic and Statistical Manual of Mental Health 
Disorders (DSM-V) criteria (Appendix A), which may result in over- diagnosing the disorder of 
ADHD.  Moreover, ADHD may be under-diagnosed by another clinician as a result of the 
direction of his or her bias.  Primary care providers (PCPs) are increasingly confronted with 
caring for individuals with this disorder and often lack knowledge and expertise in appropriate 
diagnosing and effective management of this disorder.   
	  
	  
2 
	  
 The American Academy of Pediatrics (AAP) has developed evidence-based clinical 
practice guidelines for the PCP’s to aid in the assessment, diagnosis, and treatment of children 
with ADHD (Appendix B).  Despite the availability of practice guidelines, research suggests 
underutilization of Clinical Practice Guidelines and/or use of the DSM-V diagnostic criteria in the 
family practice clinical setting (Co- et al., 2010; Rushton, Fant, & Clark, 2004).  The rather high 
prevalence of ADHD, recognition of its chronicity, and frequent presentation to family practice 
warrants that PCPs take a proactive approach in caring for this disorder (Epstein, Langberg, & 
Lichtenstein, 2010).   
 The primary focus for this practice improvement project is implementing and evaluating 
an evidence-based evaluation tool/template linked to the electronic health record (EHR) for the 
primary care setting.  The ADHD evaluation tool/template prompts the PCPs to use clinical 
practice guidelines for the assessment, diagnosis and treatment of school-aged children with 
ADHD in the family practice setting.   
 According to Madison and Stagger (2011) the use of EHR systems can improve 
communication and coordination of care, as well as promote better patient outcomes.  Embedding 
clinical practice guidelines and the DSM-V ADHD diagnostic criteria into an EHR evaluation 
tool/template will assure clinical decision support that has the potential to improve the quality and 
consistency of care provided at the ADHD clinical encounter.  The EHR evaluation tool/template 
will provide evidence-based decision support as presented to the clinician at the point of thought, 
providing critical evidence-based scientific literature that promotes timely and informed medical 
decision making to aid in optimal patient outcome (Madison & Stagger, 2011).   
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Project Statement/Purpose 
 This practice improvement project will include EHR adoption of an evaluation 
tool/template for the assessment, diagnosis, and treatment of ADHD in accordance with the 
guidelines set forth by the AAP and DSM-V, assuring evidence based practice.  The specific aim 
of this project is to implement and evaluate an EHR evaluation tool/template that will provide 
PCPs a systematic approach to a comprehensive assessment, diagnosis, and treatment of ADHD 
in school aged children.  The EHR evaluation tool/template will promote evidence based 
treatment and outcome measurements while providing evaluation of PCPs responses and 
utilization of the ADHD evaluation tool/template in the family practice setting.   
Significance of the Project 
 ADHD is rarely a solo diagnosis.  ADHD frequently presents with co-morbidities such as 
oppositional defiant disorder, anxiety, depression and learning disabilities.  Social and educational 
functional difficulties such as academic failures, school suspension, disruptive behavior, 
delinquency and peer rejection are just a few of the problems a child with ADHD may face 
(Barkley, 2006).  Adolescence with ADHD have earlier onset and higher rates of substance abuse 
than adolescence without ADHD (Ivan, Pearson, Kaplan, & Newcorn, 2010; Molina & Pelham, 
2003).  Failure to recognize ADHD and provide appropriate interventions can result in serious 
consequences; therefore early identification and treatment is essential.   
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Project Description and Purpose  
 The practice improvement project was implemented at Riverview Health Clinic in 
Crookston, MN.  The project included the implementation of an the evaluation tool/template 
embedded in Riverview’s EPIC electronic health record that provides a comprehensive evaluation 
for children ages 4-18, evaluated and treated for ADHD.  The AAP clinical practice guidelines 
and the DSM-V ADHD diagnostic criteria were linked to the EHR as a “smart phrase,” a 
computer software component of EPIC.   A “smart phrase” allows prompts and drop down menus 
which guide the primary care provider (PCP’s) in the documentation of a comprehensive 
assessment, diagnosis, and treatment of ADHD.   
Project Objectives 
 According to the AAP, a reliable diagnosis of ADHD is dependent upon the fulfillment of 
three criteria: a) the use of explicit criteria for the diagnosis using the DSM-V, b) the importance 
of obtaining information about the child’s signs in more than one setting, and c) evaluation for co-
existing conditions which may make the diagnosis more difficult or complicate treatment 
planning.  Assuring evidence-based practice in the assessment, diagnosis and treatment of 
children presenting with inattention, hyperactivity or impulsivity symptoms, the objectives of this 
clinical practice improvement project will center on fulfillment of these criteria.   
Objective #1 
The EHR ADHD Evaluation Tool/Template will provide documentation supporting the 
application of the DSM-V diagnostic criteria in the assessment, diagnosis, and treatment 
of ADHD.  
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Objective #2  
The EHR ADHD evaluation tool/template promotes documentation of screening for 
common co-morbid conditions.   
Objective #3 
The EHR ADHD evaluation tool/template will facilitate and provide documentation 
supporting an interdisciplinary team approach to the assessment, diagnosis, and treatment 
of ADHD.    
Objective #4 
Application of the evaluation tool/template will promote documentation supportive of 
evidence-based practice in the assessment, diagnosis and treatment of ADHD. 
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CHAPTER TWO 
Literature Review  
ADHD Background 
Attention deficit hyperactivity disorder (ADHD) is a complex chronic condition with 
genetic and environment causes.  The onset of ADHD occurs in early childhood characterized by 
developmentally inappropriate levels of hyperactivity, impulsivity, and/or inattention (Barkley, 
2006; Clarke, & Frank-Briggs, 2011; Clarke, Heussler, & Kohn, 2005; Resnick, 2005; Sabina, 
2012).  The prevalence of ADHD in school-aged children is estimated to be up to percent.  
ADHD is among one of the most common chronic neurobiological disorders in children.  
Untreated, children with this disorder often experience academic underachievement, low self-
esteem and difficulty with peer relationships (Childress & Berry, 2012; Co, et al., 2010; Laver-
Bradbury, 2012; Leslie, 2006; Rader, McCauley, & Callen, 2009; Wilens, & Zulauf, 2012; 
Xenitidis, Maltezos, & Pitts, 2011).   
 The diagnosis of ADHD accounts for nearly 50% of pediatric psychiatric patients (Franks-
Briggs, 2011; Gioia & Isquith, 2002; Xenitidis, Maltezos, & Pitts, 2011).  ADHD has been 
recognized and studied for over a century.  ADHD has been identified as being the most 
researched mental health disorder in our country, yet still is found to leave many in disbelief of its 
existence (Frank-Briggs, 2011; Reiff, 2011).  Society often views this disorder simply as a result 
of poor parenting, lack of child supervision and environmental factors.   
ADHD Across the Lifespan  
Sixty percent of children diagnosed with ADHD continue to manifest noticeable ADHD 
symptoms into adulthood.  The realization that ADHD often persists throughout adulthood has 
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only been addressed over the last few decades (Barkley, 2006; Clarke, Huessler, & Kohn, 2005; 
Franks-Briggs, 2011; Xenitidis, Maltezos, & Pitts, 2011).  Prior to recognizing the chronicity of 
ADHD into adulthood, research was focused primarily on the hyperactive component of the 
disorder.  Hyperactivity often decreases as one ages and because of this, ADHD was thought to 
resolve prior to or during the adolescent stage of life.  The hyperactivity component diminishes 
with age or changes to a feeling of inner restlessness, while impulsivity and inattentiveness often 
persists throughout the course of one’s life (Waite & Ramsey, 2010).   
ADHD Co-Morbid Conditions 
ADHD is rarely a solo diagnosis.  Co-morbid conditions such as mental health disorders, 
learning disorders or neurodevelopmental conditions occur in as many as two-thirds of children 
diagnosed with ADHD in the United States (Franks-Briggs, 2011).  Co-morbidities can 
complicate the assessment and treatment of this disorder (Reiff, 2011).  Frequency of co-
morbidity was revealed in a survey conducted by the National Children’s Health, revealing that 
33% of children diagnosed with ADHD had one co-morbid disorder, 16 % had two and 18% had 
three or more.  Learning disabilities account for 46%, conduct disorder 27%, anxiety 18%, 
depression 14% and speech impairment accounted for 12% of the co-morbidities (Larson, Russ, 
Kahn, & Halfon, 2011).  Oppositional defiant disorder is also highly prevalent as a co-morbidity 
of ADHD (Franks-Briggs, 2011; Power, Mautone, Manz, Frye, & Blum, 2008; Woodard, 2006).   
Children and adolescents with this disorder are at greater risk of sustaining injuries.  They 
tend to have more frequent and severe injuries then peers without ADHD.  Adolescents with 
ADHD are four times more likely to sustain a motor vehicle violation, eight times more likely to 
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have their driver’s license revoked and four times more likely to be involved in a motor vehicle 
collision than the adolescent without ADHD (Cox-et al., 2007; Reiff, 2011).   
Smoking and Substance Use 
The disorder of ADHD has been shown to be a significant predictor for the onset of 
smoking before the age of 15 and is associated with higher risk of smoking into adulthood and a 
lower likelihood of smoking cessation.  Several studies have documented a strong connection 
between ADHD, alcohol and drug abuse (Ivanov, Pearson, Kaplan, & Newcorn, 2010; Kousha, 
Shahrivar, & Alaghband-Rad, 2012; Wilens & Zufauf, 2012).   
The individual with ADHD typically has problems with alcohol and drug abuse at an 
earlier age, and the problems tends to be more severe than individuals without the disorder.  Many 
individuals with this disorder use substances as a way of self-medicating in an attempt to relieve 
the symptoms of ADHD or symptoms of associated co-morbid mental health disorder(s).  Self-
medication is often the result of undiagnosed or untreated ADHD (Sherman, 2007).   Alcohol and 
marijuana are the most common substances of abuse in children and adolescents with ADHD 
(Wilens & Zulauf, 2012).   
ADHD and Risky Behavior 
 The ADHD adolescent is often prone to risk taking behaviors, especially in the presence 
of impulsivity.  They tend to engage in first time intercourse at an earlier age.  There is a higher 
prevalence of multiple partners and less likely to use birth protection measures.  Impulsive 
behavior is often associated with a higher frequency of sexually transmitted infections and 
unintended pregnancies in comparison to peers without ADHD (Reiff, 2011).   
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ADHD and PCPs 
PCPs are increasingly confronted with treating children with ADHD.  PCPs, including 
Advanced Practice Nurses (APN) are frequently confronted with the challenges of assessment, 
diagnosis, and management of this disorder.  Diagnosing the disorder of ADHD is complex and 
multi-faceted.  Accuracy in the diagnosis requires a thorough history, competition of behavioral 
rating scales, a thorough physical exam and evaluation based on the DSM-V ADHD diagnostic 
criteria (Childress & Berry, 2012; Epstein, Langberg, & Lichtenstein, 2010; Hardy, Warmbrodt, 
& DeBasio, 2004; Vlam, 2006; Woodard, 2006).  
The American Academy of Pediatrics (AAP), American Medical Association (AMA), and 
American Academy of Child and Adolescent Psychiatry (AAPAP) have established guidelines 
and evidence-based protocols.  These guidelines are systematically developed statements 
established to assist the PCPs in the assessment, diagnosis, and treatment of ADHD (Bukstein, 
2010; Epstein, Langberg, & Lichtenstein, 2010).  A toolkit is available to aid PCPs in the 
evaluation and management of children with ADHD developed by the National Initiative for 
Children’s Healthcare Quality (NICHQ) according to AAP guidelines (Krull, 2011).  Competency 
in the assessment, diagnosis, and treatment of children with ADHD require an understanding of 
the spectrum of this condition, its comorbidities and various treatment approaches.  Despite the 
availability of evidence-based clinical practice guidelines, many PCPs are not accustomed to 
incorporating them into practice.   
A survey conducted by Rushton, Fant, and Clark (2004) of 1374 primary care physicians 
in Michigan revealed that 77% were familiar with the AAP guidelines on ADHD.  Approximately 
60% had incorporated them into their practice.  The majority of PCPs reported practice consistent 
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with individual components of the diagnostic and treatment guidelines.  However, when 
adherences to multiple components were analyzed; only 26% reported routine use of all four 
diagnostic components.  The study also found that some PCPs continue to use diagnostic 
neuroimaging and laboratory tests in routine ADHD evaluations; these modalities are no longer 
recommended.  Only 53% reported routine follow-up visits (3-4 times per year) for medication 
management of children with ADHD.   
A study involving 79 pediatricians caring for 412 children with ADHD from 12 primary 
care practice sites in Massachusetts revealed that EHR decision support improves care of children 
with ADHD.  The study involved EHR decision support with prompts reminding the pediatrician 
to assess children’s ADHD symptoms every 3 to 6 months.  Additionally, a visit note template 
provided prompts to assess and record symptoms, treatment effectiveness, and adverse effects.  
Seventy-one percent of children in the intervention group had visits assessing ADHD as opposed 
to only 54% in the control group.  The study also revealed that during routine well-child visits the 
providers were more likely to document and discuss ADHD symptoms and treatment in the 
intervention group (78%) as compared to only 63% in the controlled group.  According to the 
researchers, the use of the ADHD template was associated with better documentation of 
symptoms and treatment effectiveness.  Provider satisfaction rates on managing ADHD were 
higher among the pediatrician that had access to the decision support template (Co- et al., 2010).  
Assessment of the Disorder ADHD 
According to the AAP Clinical Practice Guidelines on ADHD, a thorough history includes 
a comprehensive interview with both the parent/caregiver and child.  The emphasis of this clinical 
interview are the diagnostic criteria set forth by the DSM-V for ADHD, as well as recognizing 
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symptoms of potential co- morbid conditions.  Questionnaires and behavioral rating scales are 
frequently used as part of the screening for the core symptoms of ADHD.  During the interview 
the clinician inquires about the 18 symptoms listed in the DSM-V.  The clinician determines the 
presence of each symptom noting age of onset, frequency, duration, and severity of each 
symptom.  The child must have the required number of symptoms (at least six of nine of the 
inattention cluster or at least six of nine of the hyperactive/impulsive criteria, each occurring more 
days then not), a chronic course (symptoms do not remit for weeks or months at a time), and onset 
of symptoms during childhood.  Following identification of symptoms, the clinician should 
determine in which setting impairment occurs.  Presence of symptoms should be distinguished 
from presence of impairment.  The DSM-V requires impairment in at least two settings (home, 
school or job) to meet criteria for this disorder (American Psychiatric Association ([DSM-V], 
2013).   
PCPs should ask specific questions pertaining to school performance as academic 
impairment is common in this disorder.  When possible, the parent/caregiver is requested to bring 
in current examples of schoolwork, report cards, and attendance records for review.  The 
frequencies of tardiness and/or problems with truancy are evaluated.  If the child has had any 
psycho-educational testing it is valuable to have a summary of outcome at the time of assessment.  
The provider inquires whether the child has repeated any grades or receiving any special 
education at present or in the past.  The provider must also determine if the child’s behaviors have 
led to suspension, either in or out of school, or served detention, and if so, what behaviors or 
problems were the reason for the disciplinary action(s).   
Following identification of symptoms, the PCPs should interview the parent(s) inquiring 
about other common childhood disorders.  The interview is then focused on screening for the 
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presence of commonly occurring co-morbid conditions.  The PCPs then determines whether the 
child meets criteria for a separate co-morbid condition in addition to ADHD, the co-morbid 
disorder is the primary disorder and the child’s inattention or hyperactivity-impulsivity is directly 
caused by it, or the co-morbid symptoms do not meet criteria for a separate disorder but represent 
secondary symptoms stemming from ADHD.  The comprehensive history includes obtaining 
information related to the child’s present and past medical history, obstetrical and perinatal 
history, developmental, family history including any significant mental health disorders, 
substance abuse disorders as well as family functioning (Barkley, 2006; Childress & Berry, 2012; 
Woodard, 2006).   
The initial evaluation of ADHD seldom requires laboratory or neurological testing.  
Neurological studies such as EEG, MRI, SPECT or PET are not indicated in the evaluation unless 
there is strong evidence of certain risk factors in the medical history.  Psychological and 
neuropsychological tests are not recommended in the evaluation of ADHD unless the child’s 
history suggests low general cognitive ability or low achievement in language or mathematics 
relative to the child’s intellectual ability (Woodard, 2006).   
Recommended Treatment 
According to the AAP, a child-specific individualized treatment plan should be developed 
for children with the goal of maximizing function to improve relationships and performance at 
school, decrease disruptive behaviors, promote safety, increase independence and self-esteem.  
PCPs should establish a treatment plan that recognizes ADHD as a chronic condition.  PCPs 
should provide age appropriate education regarding the disorder and counsel regarding family 
responses to the condition.   
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Treatment should be guided by PCPs, in collaboration with parent(s) or care giver, child 
and school personnel addressing targeted outcomes.  In the event the child fails to meet the 
targeted outcome goals, the PCPs should re-evaluate the diagnosis, use of all appropriate 
treatments, adherence to the treatment plan and presence of co-morbid conditions.  Periodic 
follow-up is suggested with ongoing monitoring directed to target outcomes and adverse effects, 
with information gathered from the parent(s), care giver, teacher, and child.   
Theoretical Framework 
As a multi-faceted disorder, ADHD requires a holistic approach to the assessment, 
diagnosis, and treatment of the disorder to assure optimal child outcome.  Neuman’s System 
Model, developed by Nurse Theorist, Betty Neuman, and was utilized to guide this clinical 
improvement project.  The Neuman’s System model is applicable as this project’s focus is that of 
the individual as a whole.  The goal of the Neuman’s System Model is providing a holistic 
overview of the physiological, psychological, social-cultural, developmental and spiritual aspects 
of human beings (Fawcett, Newman, & McAllister, 2004).   
Neuman refers to the client as being an open system.  The client, as an open system, is 
confronted by stressors from the internal and external environment.  Within the system is the 
central core that is essential in the maintenance of life.  The central core is the product of five 
variables: physiological, psychological, social-cultural, developmental and spiritual.  These 
variables are interrelated and need to be taken into consideration when addressing the client as a 
whole (George, 2002; Martsolf & Mickey, 1998).  Neuman refers to the environment as being all 
of the internal and external factors that surround or interact with the client.  Stressors are referred 
to as environmental forces that interact with and potentially alter system stability.   
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Three circles of protection surround the central core.  The inner circle is referred to as the 
line of resistance.  This inner circle acts as a barrier providing protection to the inner core of the 
system.  The second layer is referred to as the normal line of defense and the third or outermost 
circle is referred to as the flexible line of defense.  The flexible line of defense remains strong 
when the individual provides his or her body with a balance of necessities: adequate nutrition, 
exercise, sleep, hydration, and time for recreation.  These lines of protection, when in place, 
promote a state of equilibrium or wellness for the system, that being the client (Fawcett, Newman, 
& McAllister, 2004).      
This model defines health as being on a continuum of wellness to illness that is dynamic 
and continually changing.  The client is in a state of either wellness or illness, in varying degree, 
at any point of time.  As a multidimensional being, the client is confronted by internal and 
external stressors on a continuous basis.  The best possible state of health is referred to as the 
optimal state of wellness.  Being in a state of equilibrium is considered the healthy state of the 
system, while disequilibria is referred to illness.  As a wellness model, the goal is to facilitating a 
state of equilibrium. When the lines of protection become threatened or weakened by internal and 
external stressors, the client system enters a state of disequilibria or illness.  It is during that state 
that intervention is necessary.   
Neuman’s model describes three levels of intervention.  These interventions include 
primary, secondary and tertiary.  The goal of implementing these interventions is to promote 
optimal client health.  Primary intervention occurs before the system reacts to a stressor.  
Secondary intervention occurs after the system reacts to a stressor, and tertiary intervention 
occurs after the system has been treated through secondary prevention strategies (Fawcett, 
Newman, & McAllister, 2004).       .   
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The application of this model in guiding this clinical improvement project in the 
assessment, diagnosis, and treatment of ADHD is applicable as well as relevant.  Application of 
this model assures a holistic approach identifying the client’s stressors, as he or she perceives 
them.  This framework promotes a holistic approach and when applied accordingly, it not only 
provides for an accurate assessment of ADHD, but also may appear with any one of the common 
co-morbid disorders commonly associated with ADHD.  As previously discussed, the individual 
with ADHD is a multidimensional being, who is confronted with stressors on a continuous basis.  
These stressors, if not identified and addressed accordingly, often result in multi-faceted adversity 
for the client with ADHD.   
The application of the Neuman’s Theoretical Framework in guiding this clinical 
improvement project promotes a comprehensive assessment in the evaluation process of children 
with suspected ADHD.  Application of this framework in turn assures accuracy as well as validity 
in the diagnosis of ADHD.  Applying primary, secondary and tertiary interventions in the 
treatment of ADHD will assure optimal outcome (wellness) for the child confronted with the 
disorder of ADHD as well as potential co-morbid conditions.     
The evaluation tool/template assures a comprehensive approach to the assessment, 
diagnosis and treatment of ADHD in school aged children ages 4-18. The evaluation 
tool/template elicits a comprehensive history including the five variables: a) physiological, b) 
psychological, c) social-cultural, d) developmental and e) spiritual.  The child is an active 
participant in the development of an individualized plan of care identifying targeted treatment 
outcome.  The evaluation tool/template, when applied, promotes primary, secondary and tertiary 
interventions.    
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CHAPTER THREE 
Project Design 
 
 The logic model was used as a tool to guide this clinical improvement project process and 
evaluation (Appendix C).  The logic model is defined as a picture of how a project does its work.  
This model identifies the theory and assumptions underlying the project.  The model links 
outcomes (short, mid- and long-term) with project activities/process and the theoretical 
assumptions and principles of the project.  The logic model provide a visual diagram presenting 
an understanding of the relationships among resources (inputs) as well as project activities leading 
to the achievements of project objectives (outcomes).  The logic model provides a framework for 
evaluating the effectiveness of the project (Coffman, 1999).  The model also provides guidance in 
selecting data collection in the evaluation of project objectives.  
 This project consists of a retrospective chart audit of EHR of all children accessing 
services for ADHD during the 6 week study.  The retrospective chart audit elicited data in 
accordance with the data collection tool.  The data collection tool consists of evidence based 
criteria adopted from the American Academy of Pediatrics Clinical Practice Guidelines and the 
DSM-V ADHD diagnostic criteria. A PCPs Survey was also completed at the end of the study.  
The survey contained evidence-based data in accordance to the AAP Clinical Practice Guidelines 
and DSM-V ADHD diagnostic criteria.  Data from both instruments was quantitative in nature 
and analyzed using inferential statistics.   
Project Implementation 
Riverview’s EPIC PCP Coordinator adopted the DSM-V ADHD diagnostic criteria and 
the AAP Clinical Practice Guidelines into the EHR as an evaluation tool/template.  The 
evaluation tool/template was embedded in Riverview’s EPIC EHR as a “smart phrase.”  A smart 
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phrase is a component of EPIC that allows prompts and drop down menu’s which guide PCPs in 
the documentation of a comprehensive assessment, diagnosis and treatment of ADHD.  Two 
smart phrases were created, one for initial assessment and another for follow-up successive 
ADHD encounters.   
A focused forum was held for Riverview PCPs during January’s monthly provider 
meeting.  Five of Riverview’s nine PCPs attended this forum.  The project director provided PCPs 
an overview of the clinical improvement project including an educational module that contained a 
hard copy of the AAP ADHD Clinical Practice Guidelines, the DSM-V ADHD diagnostic criteria 
and directions on accessing and using the evaluation tool/template (Appendix G).  The evaluation 
tool/template was launched and utilized in the PCPs clinical setting for a period of six weeks 
(January 16th through February 28th, 2014).    
NDSU/Agency IRB Approval  
This project was granted approval to take place at Riverview’s Family Practice Clinic 
through North Dakota State University’s Institutional Review Board.  Riverview’s CEO agreed to 
allow this study to take place on-site at Riverview Clinic (Appendix F).     
Data Collection  
Riverview’s Medial Record personnel retrieved a listing of all children ages 4-18 that 
accessed services with the diagnostic ICD-9 code of 314.00 and 314.01 (ADHD without 
hyperactivity and ADHD without hyperactivity) during the 6 week period.  A retrospective chart 
audit was conducted on- site at Riverview by the project director in the collection of data as 
outlined by the data collection tool (Appendix D).  Six week post launching of the evaluation 
tool/template, a survey (Appendix E) was distributed to Riverview’s PCP with request for 
completion while assuring anonymity and confidentiality.  Data retrieved from the retrospective 
	  
	  
18 
	  
chart audit and PCPs surveys were quantitative in nature.  Data were analyzed with the 
application of inferential statistics.  
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CHAPTER FOUR 
Evaluation 
 The evaluation of project objectives was guided by the use of the logic model (Appendix 
C).  The logic model systematically connects project in-puts, project out-puts, and project 
outcomes (objectives) thereby promoting a theory of change.  A data collection tool (Appendix D) 
and a PCP survey (Appendix E) were designed to elicit data pertaining to evidence based practice  
in accordance with the American Academy of Pediatric ADHD Clinical Practice Guidelines and 
the DSM-V ADHD diagnostic criteria.  A retrospective chart audit was conducted in addition to 
the PCP survey in the retrieval of quantitative data.  Data was then analyzed using inferential 
statistics.              
Objective #1  
“The EHR ADHD evaluation tool/template will provide documentation supporting the 
application of the DSM-V diagnostic criteria in the assessment, diagnosis and treatment of 
ADHD.”  This objective was measured by a retrospective chart audit by use of the data 
collection tool.  The data collection tool questioned if the EHR provided documentation to 
support the presence of ADHD DSM-V symptoms in the assessment, diagnosis and 
treatment of ADHD. The retrospective chart audit evaluated for the presence of DSM-V 
symptom documentation in the EHR of children accessing services for ADHD during the 
study period.    
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Objective #2 
“The EHR ADHD evaluation tool/template promotes documentation of screening for 
common co-morbid conditions.”  This objective was measured by a retrospective chart 
audit by use of the data collection tool and the PCP survey.  The retrospective chart audit 
evaluated for the presence of screening for co-morbid conditions.  The PCPs survey 
questioned if the evaluation tool/template promoted screening for co-morbid conditions.  
Quantitative data were then analyzed using inferential statistics in the outcome based 
evaluation of this objective.   
Objective #3 
“The EHR evaluation tool/template will facilitate and provide documentation supporting 
an interdisciplinary team approach to the assessment, diagnosis and treatment of ADHD in 
children ages 4-18.”  This objective was measured by the retrospective chart audit and 
PCPs survey.  The use of teacher ADHD rating scales in the assessment, diagnosis and 
treatment of ADHD promotes an interdisciplinary team approach.  The evaluation of this 
objective is outcome based and guided by the use of the Logic Model.  The retrospective 
chart audit contained questions if the EHR ADHD clinic encounters documented support 
of an interdisciplinary team approach to the assessment, diagnosis and treatment of 
ADHD.  The PCPs survey also surveyed PCPS asking if the ADHD evaluation 
tool/template promotes an interdisciplinary team approach to the assessment, diagnosis 
and treatment of ADHD.  
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Objective #4 
“Application of the evaluation tool/template will promote documentation supportive of 
evidence based practice in the assessment, diagnosis and treatment of ADHD.”  This 
objective was measured by a retrospective chart audit and PCP survey responses. Both the 
data collection tool and PCPs survey includes content pertaining to the American 
Academy of Pediatric ADHD clinical practice guidelines and the ADHD diagnostic 
criteria in accordance with the DSM-V thereby promoting evidence based-practice.   
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CHAPTER FIVE 
Results 
During the six-week review there were 81 children ages 4-18 that accessed services for 
ADHD at Riverview Clinics.  A retrospective chart audit was performed to acquire data as 
outlined in the data collection tool.  Of the 81 ADHD clinic encounters, 63% documented 
utilization of the evaluation tool/template in the assessment, diagnosis and treatment of ADHD 
(n=51).  Documentation supporting the use of ADHD rating scales were 90% (n=46) with use of 
the evaluation tool/template and 17% (n=5) when the evaluation tool/template was not used (See 
Table 1).   
TABLE 1  
EHR Documentation of ADHD Evaluation Tool/Template 
EHR Documentation ADHD Clinic Encounter 
with use of the evaluation  
tool/template (n=51) 
ADHD Clinic Encounter 
without use of evaluation 
tool/template (n=30) 
Use of ADHD Rating 
Scales 
        46/51          90%              5/30          17% 
Assessing presence of 
ADHD DSM-V symptoms 
        45/51          88%        25/30          83%          
Screening for co-morbid 
conditions 
        46/51          90%          7/30          23% 
Documentation supports an 
interdisciplinary team 
approach  
        34/51          67%          9/30          30% 
Plan of care documents 
target treatment outcomes 
        51/51         100%         28/30          93% 
Presence of written 
treatment plan with patient 
education   
        51/51         100%                30/30         100% 
Recommendation for 
appropriate follow-up 
        51/51         100%         30/30         100% 
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Assessment for the presence of DSM-V symptoms in more than on setting was 
documented 88% with evaluation tool/template use (n=45) and 83% (n=25) in visits without the 
template use (see Table 1).   
The evaluation tool/template use documentation supportive of targeted treatment outcome 
100% (n=51) while encounters without evaluation tool/template was 93% (n=28).  There was 
documentation supporting that the plan of care provided a written treatment plan and appropriate 
follow-up recommended (eg. initial assessment follow-up recommended within 2-4 weeks and 
maintenance follow-up recommended a minimum of every 3-4 months) 100% of encounters with 
or without evaluation tool/template use (n=81).   
A five point likert scale survey was dispersed to Riverview’s eight primary care providers 
following the six week evaluation tool/template launching with a response rate of 75% (n=6).  
The likert scale included six questions pertaining to the evaluation tool/template (Appendix E).   
Question one asked if the ADHD evaluation tool/template was easy to access within the 
electronic health record. There were five strongly agree (83%) and 1 agree (N=6).  Question two 
asked if the ADHD tool/template promotes an interdisciplinary team approach to the assessment, 
diagnosis, and treatment of children with ADHD.  All six respondents strongly agreed.  Question 
3 asked if the evaluation tool/template promotes documentation of evidence-based practice.  
Again, all 6 responded strongly agreed.   
Question four asked if the evaluation tool/template promoted screening for common co-
morbid conditions.  Of the 6 respondents, 5 strongly agreed (83%) and 1 agreed.   Question five 
asked if the evaluation tool/template is clear and concise and improves work flow in the family 
practice setting.  There were 4 respondents whom strongly agreed (67%) and 2 agreed (33%).  
The final question asked if the primary care provider was comfortable in using the ADHD 
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evaluation tool/template.  All 6 responded strongly agreed.  Table 2 below summarizes the survey 
results.    
TABLE 2 
Primary Care Providers Likerts Scale Survey 
PCPs Survey 
Questions 
1=Strongly 
Agree 
2=Agree 3=Neutral 4=Disagree 5=Strongly 
Disagree 
Tool/ template 
is easy to access 
in the EHR 
 
     83% 
 
     17% 
 
     0% 
 
     0% 
 
     0% 
Promotes an 
interdisciplinary 
team approach 
 
    100% 
 
     0% 
 
     0% 
 
     0% 
 
     0% 
Promotes  
evidence-based 
practice 
 
    100% 
 
     0% 
 
     0% 
 
     0% 
 
     0% 
Promotes 
screening for 
co-morbid 
conditions  
 
    83% 
 
    17% 
 
     0% 
 
     0% 
 
     0% 
Tool/template is 
clear/concise 
and improves 
workflow 
 
    67% 
 
    33% 
 
     0% 
 
     0% 
 
     0% 
PCP comfort in 
using the tool/ 
template  
 
    100% 
 
     0% 
 
     0% 
 
     0% 
 
     0% 
 
Project Objective #1 
The EHR ADHD Evaluation Tool/Template will provide documentation supporting the 
application of the DSM-V diagnostic criteria in the assessment, diagnosis, and treatment 
of ADHD.  This objective was met as evident by the retrospective chart audit which 
revealed that when the evaluation tool/template was used, it provided documentation in 
support of the DSM-V symptoms in 88% of clinic encounters.   
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Project Objective #2 
The EHR ADHD evaluation tool/template promotes documentation of screening for 
common co-morbid conditions.  This objective is met as evident by results of the 
retrospective chart audit and PCPs Survey.  The retrospective chart audit revealed a 90% 
presence of screening for co-morbid conditions with the use of the ADHD evaluation 
tool/template in comparison to 23% of visits that did not use the Tool.  The PCPs survey 
questioned if the ADHD Evaluation tool/template provided screening for co-morbid 
conditions with a response rate of 83% strongly agree and 1 agree.     
Project Objective #3  
The EHR ADHD evaluation tool/template will facilitate and provide documentation 
supporting an interdisciplinary team approach to the assessment, diagnosis, and treatment 
of ADHD.   This objective was met as evident by both the retrospective chart audit and the 
PCPs survey.  The retrospective chart audit revealed documentation supportive of an 
interdisciplinary team approach 67% in comparison to 30% of the time when the ADHD 
Evaluation tool/Template was not used.  The PCPs survey questioned if the ADHD 
Evaluation Tool/Template promoted an interdisciplinary team approach with a response of 
100% of PCPs strongly agreeing.    
Project Objective #4 
Application of the evaluation tool/template will promote documentation supportive of 
evidence based practice in the assessment, diagnosis and treatment of ADHD.  This 
objective was met by evidence of the PCPs Survey.  The survey questioned if the ADHD 
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Evaluation Tool/Template promotes evidence-based practice.  The PCPs survey response 
was 100% strongly agree.   
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CHAPTER SIX 
Discussion and Recommendations 
Interpretation of Results 
Use of the evaluation tool/template promotes documentation supportive of evidence-based 
practice in the assessment, diagnosis and treatment of ADHD.  There was a higher frequency in 
the use of rating scales and co- morbid condition screening with the use of the evaluation 
tool/template as opposed to without.  There was a higher frequency in the assessment of the 
DSM-V symptoms and documentation of targeted treatment outcome when the evaluation 
tool/template was applied. The use of the evaluation tool/template promotes an interdisciplinary 
approach to the assessment, diagnosis and treatment of children with ADHD.   
Limitations/Future Research 
Limitations of this study are that it took place in a single setting with limited primary care 
providers.  The study length of duration was only six weeks.  Additionally, this project included 
children with and without co-morbid conditions.  Data analysis did not differentiate use of the 
ADHD evaluation tool/template in comparison of children with versus without co-morbid 
conditions.  Future practice improvement projects could be conducted in multiple family practice 
settings while expanding the duration of time studied using a larger sample size while evaluating 
more PCPs.  Future practice improvement projects could focus on the impact of the child 
evaluating child outcome with the use of the ADHD evaluation tool/template.     
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Recommendations for Riverview  
It is recommended that the ADHD evaluation tool/template continue to be utilized in the 
assessment, diagnosis, and treatment of children ages 4-18 accessing services in Riverview’s 
Clinic.  A post project focused forum could be planned for Riverview’s PCPs in the dissemination 
of project outcomes.  The post project forum would allow for additional education on the ADHD 
evaluation tool/template and aid in further discussion.  PCPs feedback at a post project forum may 
result in evaluation tool/template revisions to further improve workflow and aid in higher use of 
this tool thereby promoting evidence based-practice.  This clinical improvement project is in 
alignment with Riverview’s organizational mission statement, that of delivering personalized 
exceptional care engaging in best practices to heal people and promote healthy communities.  
When utilized, the ADHD evaluation tool/template promotes documentation supporting the 
application of evidence-based practice.    
Implications for Future Research 
Dissemination of project outcome could be presented via power point presentations to area 
family practice clinics.  Project outcome could also be discussed with EPIC IT representatives 
allowing them to provide the evaluation tool/template to other family practice clinics in which 
they contract with.  Broadening the use of this evaluation tool/template to surrounding clinics will 
further promote evidence-based practice in servicing the population of children with ADHD, 
thereby promoting optimal child outcome.    
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Role of the DNP   
The Advanced Practice Nurse, educated at the Doctor of Nursing Practice (DNP) level 
could provide a major breakthrough in the promotion of improved access, as well as providing a 
holistic approach to servicing the population of children with ADHD.  Providers specializing in 
this disorder are often difficult to access, particularly in the rural setting.  The complexity of this 
disorder requires the clinician to have the highest level of scientific knowledge and practice 
expertise to ensure high quality outcome.  The DNP represents a practice-focused doctorate 
degree geared towards APN who are pursuing expert clinical practice in the clinical setting.   
Educated at the DNP level provides the APN with a wide array of knowledge.  The APN 
is able to translate this knowledge quickly and effectively in the clinical setting resulting in 
excellence in child outcome.  The DNP is skilled in synthesis, analysis and application of research 
in the clinical setting.  The DNP can assume leadership roles and act as a change agent in the 
clinical setting advocating the application of evidence-based practice to the clinical setting.    
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APPENDIX A. DSM-V DIAGNOSTIC CRITERIA FOR ATTENTION DEFICIT 
HYPERACTIVITY DISORDER 
(American Psychiatric Association [DSM-V], 2013) 
A. A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with 
functioning or development, as characterized by (1) and/or (2): 
1. Inattention:  Six (or more) of the following symptoms have persisted for at least 6 months to 
a degree that is inconsistent with developmental level and that negatively impacts directly on 
social and academic/occupational activities.   
Note:  The symptoms are not solely a manifestation of oppositional behavior, defiance, 
hostility, or failure to understand tasks or instructions.  For older adolescents and adults (age 
17 and older), at least 5 of the symptoms are required.   
a. Often fails to give close attention to details or makes careless mistakes in schoolwork, 
at work, or during other activities (e.g., overlooks or misses details, work is 
inaccurate).  
b. Often has difficulty sustaining attention in tasks or play activities (e.g. has difficulty 
remaining focused during lecture, conversations, or lengthy reading).  
c. Often does not seem to listen when spoken to directly (e.g., mind seems elsewhere, 
even in the absence of any obvious distraction).  
d. Often does not follow through on instructions and fails to finish schoolwork, chores, or 
duties in the workplace (e.g., starts tasks but quickly loses focus and is easily 
sidetracked).   
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e. Often has difficulty organizing tasks and activities (e.g., difficulty managing 
sequential tasks; difficulty keeping materials and belongings in order; messy, 
disorganized work; has poor time management; fails to meet deadlines).   
f. Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental 
efforts (e.g., schoolwork, homework; for older adolescents and adults, preparing 
reports, completing forms, reviewing lengthy papers).   
g. Often loses things necessary for tasks or activities (e.g., school materials, pencils, 
books, tools, wallets, keys, paperwork, eyeglasses, mobile phones).   
h. Is often easily distracted by extraneous stimuli (for older adolescents and adults, may 
include unrelated thoughts).   
i. Is often forgetful in daily activities (e.g., doing chores, running errands; for older 
adolescents and adults, returning calls, paying bills, keeping appointments).    
2. Hyperactivity and impulsivity:  Six (or more) of the following symptoms have persisted for 
at least 6 months to a degree that is inconsistent with developmental level and that negatively 
impacts directly on social or academic/occupational activities.   
Note:  The symptoms are not solely a manifestation of oppositional behavior, defiance, 
hostility, or a failure to understand tasks or instructions.  For older adolescents and adults 
(ages 17 and older), at least five symptoms are required. 
a. Often fidgets with or taps hands or feet or squirms in seat. 
b. Often leaves seat in situations when remaining seated is expected (e.g., leaves his or 
her place in the classroom, in the office, or other workplace, or in other situations that 
require remaining in place).  
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c. Often runs about or climbs in situations where it is inappropriate.  (Note: in 
adolescents or adults, may be limited to feelings of restless).   
d. Often unable to play or engage in leisure activities quietly.   
e. Is often “on the go,” acting as if “driven by a motor” (e.g., is unable to be or 
uncomfortable being still for extended time, as in restaurants, meetings; may be 
experienced by others as being restless or difficult to keep up with).   
f. Often talks excessively. 
g. Often blurts out answers before a question has been completed (e.g., completes 
people’s sentences; cannot wait for turn in conversation).   
h. Often has difficulty waiting his or her turn (e.g., while waiting in line).  
i. Often interrupts or intrudes on others (e.g., butts into conversations, games, or 
activities; may start using other people’s things without asking or receiving 
permission; for adolescents and adults, may intrude into or take over what others are 
doing).   
B. Several inattentive or hyperactive-impulsive symptoms were present prior to the age of 12 
years. 
C. Several of the inattentive or hyperactive-impulsive symptoms are present in two or more 
settings (e.g., at home, school, work; with friends or relatives; in other activities).   
D. There is clear evidence that the symptoms interfere with, or reduce the quality of, social, 
academic, or occupational functioning. 
E. The symptoms do not occur exclusively during the course of schizophrenia or other 
 psychiatric disorder and are not better explained by another mental disorder (e.g., mood 
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 disorder, anxiety disorder, dissociative disorder, personality disorder, substance 
 intoxication or withdrawal).   
Specify whether: 
314.01 (F90.2) Combined presentation:  If both Criterion A1 (inattention) and Criterion A2 
(hyperactive-impulsivity) are met for the past 6 months.   
314.00 (F90.0) Predominantly inattentive presentation:  If Criterion A1 (inattention is met 
but Criterion A2 (hyperactivity-impulsivity) is not met for the past 6 months.   
314.01 (F90.1) Predominantly hyperactive-impulsive presentation:  If Criterion A2 
(hyperactivity-impulsivity) is met and Criterion A1 (inattention) is not met for the past 6 
months.   
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APPENDIX B. AMERICAN ACADEMY OF PEDIATRICS CLINICAL PRACTICE 
GUIDELINES 
ADHD: Clinical Practice Guidelines for the Diagnosis, Evaluation and Treatment of Attention-
Deficit/Hyperactivity Disorder in Children and Adolescents 
Summary of key action statements: 
1. The primary care clinician should initiate an evaluation for ADHD for any child 4 through 
18 years of age who presents with academic or behavioral problems and symptoms of 
inattention, hyperactivity, or impulsivity. 
2. To make a diagnosis of ADHD, the primary care clinician should determine that 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria have been 
met (including documentation of impairment in more than 1 major setting); information 
should be obtained primarily from reports from parents or guardian, teachers, and other 
school and mental health clinicians involved in the child’s care.  The primary care 
clinician should also rule out any alternative cause.   
3. In the evaluation of a child for ADHD, the primary care clinician should include 
assessment for other conditions or behavioral (eg, anxiety, depression, oppositional 
defiant, and conduct disorders), developmental (eg, learning and language disorders or 
other neurodevelopmental disorders), and physical (eg, tics, sleep apnea) conditions. 
4. The primary care clinician should recognize ADHD as a chronic condition and, therefore, 
consider children and adolescents with ADHD as children and youth with special health 
care needs should follow the principles of the chronic care model and the medical home. 
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5. Recommendations for treatment of children and youth with ADHD vary depending on the 
patient’s age. 
a. For preschool-aged children (4-5 years of age), the primary care clinician should 
prescribe evidence-based parent- and/or teacher-administered behavior therapy as 
the first line of treatment and may prescribe methylphenidate if the behavior 
interventions do not provide significant improvement and there is moderate-to-
severe continuing disturbance in the child’s function.  In areas where evidence-
based behavioral treatments are not available, the clinician needs to weigh the risks 
of starting medications at an early age against the harm of delaying diagnosis and 
treatment.  
b. For elementary school-aged children (6-11 years of age), the primary care clinician 
should prescribe US Food and Drug Administration-approved medication for 
ADHD and/or evidence-based parent- and/or teacher-administered behavior 
therapy as treatment for ADHD, preferably both.  The evidence is particularly 
strong for stimulant medications and sufficient but less strong for atomoxetine, 
extended-release guanfacine, and extended-release clonidine (in that order).  The 
school environment, program, or placement is a part of any treatment plan.   
c. For adolescents (12-18 years of age), the primary care clinician should prescribe 
Food and Drug Administration-approved medication for ADHD with the assent of 
the adolescent and may prescribe behavior therapy as treatment for ADHD, 
preferably both.   
6.  The primary care clinician should titrate doses of medication for ADHD to achieve 
maximum benefit with minimum adverse effects.   
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APPENDIX C. LOGIC MODEL 
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APPENDIX D. DATA COLLECTION TOOL FOR THE ADHD EVALUATION 
TOOL/TEMPLATE 
MR#    MR#    MR#    MR#    MR#  
Evaluation Tool/Template was used in the   Y/N Y/N  Y/N  Y/N   Y/N  
documentation of today’s clinic encounter 
 
Documentation supports the use of rating scale(s) Y/N Y/N Y/N  Y/N   Y/N 
 
Documentation reflects assessing for the presence Y/N Y/N Y/N  Y/N   Y/N 
of DSM-V symptoms in more than one setting 
 
Documentation reflects screening for common Y/N Y/N Y/N  Y/N   Y/N 
co-morbid conditions  
  
Documentation reflects an interdisciplinary   Y/N Y/N Y/N   Y/N    Y/N 
team approach to the assessment, diagnosis and  
treatment of ADHD       
 
Plan of care documents targeted treatment outcome Y/N Y/N Y/N  Y/N    Y/N 
 
Plan of care provides a written treatment   Y/N Y/N Y/N  Y/N       Y/N 
plan of care including patient education      
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Appropriate follow-up recommended (eg. initial  Y/N Y/N Y/N  Y/N   Y/N 
assessment follow-up suggested within 2-4 weeks   
and maintenance follow-up suggested a minimum  
of every 3-4 months).     
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APPENDIX E. RIVERVIEW’S PRIMARY CARE PROVIDER SURVEY OF THE  
ADHD EVALUATION TOOL/TEMPLATE 
As a Primary Care provider your participation in completing this survey is optional.  Your 
feedback is highly encouraged in the promotion of evidence-based practice in servicing children 
with ADHD in Riverview’s clinical practice setting.  Upon completion, please return survey to 
the designated secured drop box located at Riverview’s family practice clinic.   
1= strongly agree 
2= agree 
3= neutral 
4= disagree 
5= strongly disagree 
 
1. The ADHD evaluation tool/template is easy to access within the electronic health 
record? 
1  2  3  4  5 
      2.   The ADHD evaluation tool/template promotes and interdisciplinary team  
 approach to the assessment, diagnosis and treatment of children with ADHD? 
 1  2  3  4  5 
      3.   The ADHD evaluation tool/template promotes documentation of evidence-based 
 practice? 
 1  2  3  4  5 
      4.   The ADHD evaluation tool/template promotes screening for common comorbid 
 conditions? 
 1  2  3  4  5 
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      5.   The ADHD evaluation tool/template is clear and concise and improves the work  
 flow in the family practice setting? 
 1  2  3  4  5 
      6.   As a primary care provider, I am comfortable in using the ADHD evaluation  
 tool/template? 
 1  2  3  4  5 
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APPENDIX F. RIVERVIEW HEALTH CONSENT FOR CLINICAL PRACTICE 
IMPROVEMENT PROJECT
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APPENDIX G. RIVERVIEW PRIMARY CARE PROVIDER TRAINING MODULE: ADHD 
EVALUATION TOOL/TEMPLATE 
The ADHD evaluation tool was designed to aid in the documentation of assessment, 
diagnosis, and treatment of children age 4-18.  When utilized, this tool assures the application of 
the DSM-V ADHD diagnostic criteria as well as adherence with the American Academy of 
Pediatrics’ Clinical Practice Guidelines in the assessment, diagnosis and treatment of children 
with ADHD.   
 The ADHD evaluation tool exists within the electronic health record as a smart phrase and 
in its current form is meant to be used during an initial evaluation for ADHD and follow-up visits.  
The evaluation tool/template exists within the EHR note section as a smart phrase that will 
specifically review a child’s ADHD symptoms and his/her response to treatment.  There are two 
parts to the evaluation tool/template.  The first part, titled:  .RVADHDEVAL is used for the 
initial assessment, diagnosis, and treatment of children presenting for an initial ADHD evaluation.  
Part 2, titled:  .RVADHDFUEVAL is used for follow-up and ongoing management of a child 
with diagnosed ADHD.   
This educational module includes the DSM-V diagnostic criteria for ADHD (appendix H) 
along with the AAP Clinical Practice Guidelines (appendix I).  This training module also includes 
hard copies of the smart phrases .RVADHDEVAL (appendix J) and .RVADHDFUEVAL 
evaluation tool/templates (appendix K).   
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APPENDIX H. DSM-V DIAGNOSTIC CRITERIA FOR ATTENTION DEFICIT 
HYPERACTIVITY DISORDER 
 (American Psychiatric Association [DSM-V], 2013)  
F. A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with 
functioning or development, as characterized by (1) and/or (2): 
3. Inattention:  Six (or more) of the following symptoms have persisted for at least six 
months to a degree that is inconsistent with developmental level and that negatively 
impacts directly on social and academic/occupational activities.   
Note:  The symptoms are not solely a manifestation of oppositional behavior, 
defiance, hostility, or failure to understand tasks or instructions.  For older adolescents 
and adults (age 17 and older), at least five of the symptoms are required.   
j. Often fails to give close attention to details or makes careless mistakes in 
schoolwork, at work, or during other activities (e.g., overlooks or misses details, 
work is inaccurate).  
k. Often has difficulty sustaining attention in tasks or play activities (e.g. has 
difficulty remaining focused during lecture, conversations, or lengthy reading).  
l. Often does not seem to listen when spoken to directly (e.g., mind seems elsewhere, 
even in the absence of any obvious distraction).  
m. Often does not follow through on instructions and fails to finish schoolwork, 
chores, or duties in the workplace (e.g., starts tasks but quickly loses focus and is 
easily sidetracked).   
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n. Often has difficulty organizing tasks and activities (e.g., difficulty managing 
sequential tasks; difficulty keeping materials and belongings in order; messy, 
disorganized work; has poor time management; fails to meet deadlines).   
o. Often avoids, dislikes, or is reluctant to engage in tasks that require sustained 
mental efforts (e.g., schoolwork, homework; for older adolescents and adults, 
preparing reports, completing forms, reviewing lengthy papers).   
p. Often loses things necessary for tasks or activities (e.g., school materials, pencils, 
books, tools, wallets, keys, paperwork, eyeglasses, mobile phones).   
q. Is often easily distracted by extraneous stimuli (for older adolescents and adults, 
may include unrelated thoughts).   
r. Is often forgetful in daily activities (e.g., doing chores, running errands; for older 
adolescents and adults, returning calls, paying bills, keeping appointments).    
4. Hyperactivity and impulsivity:  Six (or more) of the following symptoms have 
persisted for at least 6 months to a degree that is inconsistent with developmental  
level and that negatively impacts directly on social or academic/occupational 
activities.   
Note:  The symptoms are not solely a manifestation of oppositional behavior, 
defiance, hostility, or a failure to understand tasks or instructions.  For older 
adolescents and adults (ages 17 and older), at least five symptoms are required. 
j. Often fidgets with or taps hands or feet or squirms in seat. 
k. Often leaves seat in situations when remaining seated is expected (e.g., leaves his 
or her place in the classroom, in the office, or other workplace, or in other 
situations that require remaining in place).  
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l. Often runs about or climbs in situations where it is inappropriate.  (Note: in 
adolescents or adults, may be limited to feelings of restless).   
m. Often unable to play or engage in leisure activities quietly.   
n. Is often “on the go,” acting as if “driven by a motor” (e.g., is unable to be or 
uncomfortable being still for extended time, as in restaurants, meetings; may be 
experienced by others as being restless or difficult to keep up with).   
o. Often talks excessively. 
p. Often blurts out answers before a question has been completed (e.g., completes 
people’s sentences; cannot wait for turn in conversation).   
q. Often has difficulty waiting his or her turn (e.g., while waiting in line).  
r. Often interrupts or intrudes on others (e.g., butts into conversations, games, or 
activities; may start using other people’s things without asking or receiving 
permission; for adolescents and adults, may intrude into or take over what others 
are doing).   
G. Several inattentive or hyperactive-impulsive symptoms were present prior to the age of 12 
years. 
H. Several of the inattentive or hyperactive-impulsive symptoms are present in two or more 
settings (e.g., at home, school, work; with friends or relatives; in other activities).   
I. There is clear evidence that the symptoms interfere with, or reduce the quality of, social, 
academic, or occupational functioning. 
J. The symptoms do not occur exclusively during the course of a schizophrenia or other 
psychiatric disorder and are not better explained by another mental disorder (e.g., mood 
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disorder, anxiety disorder, dissociative disorder, personality disorder, substance 
intoxication or withdrawal).   
Specify whether: 
314.01 (F90.2) Combined presentation:  If both Criterion A1 (inattention) and Criterion A2 
(hyperactive-impulsivity) are met for the past 6 months.   
314.00 (F90.0) Predominantly inattentive presentation:  If Criterion A1 (inattention is met 
but Criterion A2 (hyperactivity-impulsivity) is not met for the past 6 months.   
314.01 (F90.1) Predominantly hyperactive-impulsive presentation:  If Criterion A2 
(hyperactivity-impulsivity) is met and Criterion A1 (inattention) is not met for the past 6 
months.   
Specify if:  
In partial remission:  When full criteria were previously met, fewer than the full criteria 
have been met for the last 6 months, and the symptoms still result in impairment in social, 
academic, or occupational functioning.   
Specify Current Severity: 
Mild:  Few, if any, symptoms in excess of those required to make the diagnosis are present, 
and symptoms result in no more than minor impairments in social or occupational 
functioning.  
Moderate:   Symptoms or functional impairment between “mild” and “severe” are present.  
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Severe:  Many symptoms in excess of those required to make the diagnosis, or several 
symptoms that are particularly severe, are present, or the symptoms result in marked 
impairment in social or occupational functioning.   
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APPENDIX I. AMERICAN ACADEMY OF PEDIATRICS CLINICAL PRACTICE 
GUIDELINES 
ADHD: Clinical Practice Guidelines for the Diagnosis, Evaluation and Treatment of Attention-
Deficit/Hyperactivity Disorder in Children and Adolescents 
Summary of key action statements: 
1. The primary care clinician should initiate an evaluation for ADHD for any child 4 through 
18 years of age who presents with academic or behavioral problems and symptoms of 
inattention, hyperactivity, or impulsivity. 
2. To make a diagnosis of ADHD, the primary care clinician should determine that the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria have been 
met (including documentation of impairment in more than 1 major setting); information 
should be obtained primarily from reports from parents or guardian, teachers, and other 
school and mental health clinicians involved in the child’s care.  The primary care 
clinician should also rule out any alternative cause.   
3. In the evaluation of a child for ADHD, the primary care clinician should include 
assessment for other conditions or behavioral (eg, anxiety, depression, oppositional 
defiant, and conduct disorders), developmental (eg, learning and language disorders or 
other neurodevelopmental disorders), and physical (eg, tics, sleep apnea) conditions. 
4. The primary care clinician should recognize ADHD as a chronic condition and, therefore, 
consider children and adolescents with ADHD as children and youth with special health 
care needs should follow the principles of the chronic care model and the medical home. 
5. Recommendations for treatment of children and youth with ADHD vary depending on the 
patient’s age. 
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a. For preschool-aged children (4-5 years of age), the primary care clinician should 
prescribe evidence-based parent- and/or teacher-administered behavior therapy as 
the first line of treatment and may prescribe methylphenidate if the behavior 
interventions do not provide significant improvement and there is moderate-to-
severe continuing disturbance in the child’s function.  In areas where evidence-
based behavioral treatments are not available, the clinician needs to weigh the risks 
of starting medications at an early age against the harm of delaying diagnosis and 
treatment.  
b. For elementary school-aged children (6-11 years of age), the primary care clinician 
should prescribe US Food and Drug Administration-approved medication for 
ADHD and/or evidence-based parent- and/or teacher-administered behavior 
therapy as treatment for ADHD, preferably both.  The evidence is particularly 
strong for stimulant medications and sufficient but less strong for atomoxetine, 
extended-release guanfacine, and extended-release clonidine (in that order).  The 
school environment, program, or placement is a part of any treatment plan.   
c. For adolescents (12-18 years of age), the primary care clinician should prescribe 
Food and Drug Administration-approved medication for ADHD with the assent of  
the adolescent and may prescribe behavior therapy as treatment for ADHD, 
preferably both.   
6.  The primary care clinician should titrate doses of medication for ADHD to achieve 
maximum benefit with minimum adverse effects.   
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APPENDIX J. RIVERVIEW INITIAL ADHD EVALUATION (.RVADHDEVAL)  
IMPRESSION: ADHD (Attention Deficit Hyperactivity Disorder)  
ADHD (Attention Deficit Hyperactivity Disorder), Combined Type 
ADHD (Attention Deficit Hyperactivity Disorder), Inattentive 
ADHD (Attention Deficit Hyperactivity Disorder), Hyperactive-
Impulsive  
 
PLAN:  Counseling was given on academic/study skills, drug potential side effects, and behavior 
at school and home.  Patient was provided with a written ADHD Management Plan. 
 
Management: *** 
 
Medication: *** 
 
Titration Follow-up Plan: *** 
 
Behavioral Counseling: *** 
 
School:  *** 
 
Other Specialist Referral: *** 
 
Follow-up office visit scheduled for *** 
 
Targeted outcome/treatment goal (specific criteria, eg. homework done, decrease school 
disciplinary notes) *** 
 
*** Minutes spent face-to-face with the patient.  Over 50 percent of the visit was spent in 
counseling the patient.  
 
 
 
INFORMATION OBTAINED: Parent 
     Patient 
     Teacher 
     Other *** 
 
CHIEF CONCERN(S): *** 
 
HPI: *** 
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EDUCATIONAL BACKGROUND: 
 
School: *** 
Grade:  *** 
Favorite subject:  *** 
Least favorite subject:  *** 
504/IEP:  Y/N 
Speech/OT:  Y/N 
Para Services:  Y/N 
 
 
Problem areas: Math 
   Reading/English 
   Spelling 
   Science 
   Phy Ed. 
   Homework 
   Chores 
   Peer Relationships 
 
SIGNIFICANT PAST MEDICAL HISTORY: 
 
Birth History:  *** 
 
Health History:  *** 
 
Developmental/Behavioral History: *** 
 
Pertinent Family History:  *** 
 
Psycho-social Stressors (past/present): *** 
 
ADHD DIAGNOSTIC ASSESSMENT:   
 
Rating Scales Used:  Y/N (Yes) Scale used:   NICHQ Vanderbilt-Parent 
       NICHQ Vanderbilt-Teacher 
       Other *** 
 
 
 
PARENT REPORT 
 
Inattentive - total number of questions scored 2 or 3 in questions 1-9:  /9 
Hyperactive/Impulsive - total number of questions scored 2 or 3 in questions 10-18  /9 
Total Symptoms Score for questions 1-18:   /54 
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SCREENING FOR COMORBIDITIES 
 
From Parent NICHQ Vanderbilt: 
 
/8 Oppositional-Defiant Disorder is screened by 4 of 8 symptoms (scores of 2 or 3 are 
positive) (questions 19 through 26) AND a score of 4 or 5 on any of the 8 Performance 
Section items. 
 
/14 Conduct Disorder is screened by 3 of 14 symptoms (scores of 2 or 3 are positive)  
(questions 27 through 40) AND a score of 4 or 5 on any of the 8 Performance Section 
items. 
 
/7 Anxiety/Depression are screened by 3 of 7 symptoms (scores of 2 or 3 are positive) 
(question 41 through 47) AND a score of 4 or 5 on any of the 8 Performance Section 
items.   
 
Performance Impairment questions 48-55; scores of 4 or 5 are positive  /8 
Average Performance Score: *** 
 
TEACHER REPORT 
 
Number of teacher reports:   1 
     2 
     3 
     4 
 
Inattentive - number of questions scores of 2 or 3 in questions 1-9:   /9 
Hyperactive/Impulsive - number of questions scores of 2 or 3 in questions 10-18:   /9 
Total Symptom Score for questions 1-18:   /54 
 
 
SCREENING FOR COMORBIDITIES 
 
From Teacher NICHQ Vanderbilt:  Scores of 2 or 3 on a single item reflect Often-occurring 
behaviors. 
 
/10 Oppositional-Defiant/Conduct Disorder are screened by 3 of 10 items (scores of 2 or 3 
are positive) (question 19 through 28) AND a score of 4 or 5 on any of the 8 Performance 
Section items. 
/7 Anxiety/Depression are screened by 3 of 7 symptoms (scores of 2 or 3 are positive) 
(question 29 through 35) AND a score of 4 or 5 on any of the 8 Performance Section 
items. 
 
Performance Impairment – total number of questions scored 4 or 5 in questions 36-43:  /8 
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Average Performance Score: *** 
 
Y/N   Some hyperactive-impulsive or inattention symptoms that caused impairment were  
 Present before the age of 7 years. 
 
Y/N   Some impairment from the symptoms is present in two or more settings (e.g., at  
          school, work, or at home).   
 
Y/N   There must be clear evidence of clinically significant impairment in social,  
          academic, or occupational functioning.  
 
Y/N   The symptoms do not occur exclusively during the course of a Pervasive  
          Developmental Disorder, Schizophrenia, or other Psychotic Disorder and are not  
          better accounted for by another mental health disorder (e.g. Mood Disorder,  
          Anxiety Disorder, Dissociative Disorder, or Personality Disorder  
 
 
 
From Other Sources: 
 
Mental health problems/ Learning disabilities *** 
 
Other medical conditions *** 
 
Assessment:  
 
Y/N   ADHD, INATTENTIVE subtype requires 6 out of 9 symptoms (scores of 2 or 3 are  
positive) on items 1 through 9 AND a performance problem (scores of 4 or 5) in any of the 
items on the Performance Section for both the Parent and Teacher Assessment Scales.   
 
Y/N   ADHD, HYPERACTIVE-IMPULSIVE subtype requires 6 out of 9 symptoms  
(scores of 2 or 3 are positive) on items 10 through 18 AND a performance problem (scores 
of 4 or 5) in any of the items on the Performance Section for both the Parent and Teacher 
Assessment Scales.  
 
Y/N   ADHD COMBINED inattention/hyperactivity-impulsive requires the above criteria  
 On both Inattentive and Hyperactive/Impulsive subtypes.  
 
Y/N   ADHD not otherwise specified.   
 
Y/N   Does not meet criteria for ADHD.   
 
 
 
**See scanned document under media for full disclosure of Vanderbilt Assessment Scale. 
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APPENDIX K. RIVERVIEW ADHD FOLLOW-UP EVALUATION/TEMPLATE 
(.RVADHDFUEVAL) 
IMPRESSION: ADHD (Attention Deficit Hyperactivity Disorder) 
   ADHD, combined Type 
   ADHD, Inattentive  
   ADHD, Hyperactive-Impulsive  
	  
PLAN:  Counseling was provided on academic/study skills, drug potential side effects, and 
behavior at school and home.  Patient was provided a written ADHD medication plan.  
  
Management: *** 
Recommended follow-up: *** 
 
*** Minutes spent face-to-face with patient.  Over 50% of the visit was spent counseling the 
patient. 
 
 
CHIEF COMPLAINT:   @CHIEFCOMPLAINT@ (This will pull from the chart) 
 
HPI: *** 
 
Child is currently on ***.  Effects of the medication are ***.  Parental concerns ***.  Childs 
perception of current treatment ***. 
 
 
EDUCATIONAL BACKGROUND: 
 
School:  *** 
Grade: 1,2,3,4,5,6,7,8,9,10,11,12 
 
Y/N   Significant past medical history reviewed/Updated (health history, developmental/ 
          behavioral, and psycho-social stressors.  
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ADHD DIAGNOSTIC ASSESSMENT:   
 
Rating Scales Used:  Y/N (Yes) Scale used:     NICHQ Vanderbilt-Parent 
               NICHQ Vanderbilt-Teacher 
               Other ***   
 
Summary of rating scales for today’s review.  Scoring is reflective of current treatment. 
 
NICHQ Vanderbilt Assessment Scale – Parent Informant 
 
Total # of questions scored 2 or 3 in questions 1-9:     /9 
 
Total # of questions scored 2 or 3 in questions 10-18:     /9 
  
Total Symptom score for questions 1-18:     /54 
 
Total # of question scored 2 or 3 in questions 19-26:     /8 
 
Total # of questions scored 2 or 3 in questions 27-40: /14 
 
Total # of questions scored 2 or 3 in questions 41-47: /7 
 
Total # of questions scored 2 or 3 in questions 48-55: /8 
 
Average Performance Score:  *** 
 
 
TEACHER REPORT 
 
Number of teacher reports:  1 
     2 
     3 
     4 
 
Total # of questions scored 2 or 3 in questions 1-9:     /9 
 
Total # of questions scored 2 or 3 in questions 10-18:     /9 
  
Total Symptom score for questions 1-18:     /54 
 
Total # of question scored 2 or 3 in questions 19-28:     /10 
 
Total # of questions scored 2 or 3 in questions 29-35:     /7 
  
Total # of questions scored 2 or 3 in questions 36-43:     /8 
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Average Performance Score:  *** 
 
**See scanned document under media for full disclosure of Vanderbilt Assessment Scale. 
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APPENDIX L. EXECUTIVE SUMMARY 
	   Results of the retrospective chart audit revealed a higher rate in documentation supportive 
of evidence-based practice when the evaluation tool/template was used.  Results of the PCP 
survey reflect that the tool contained appropriate content in the documentation of evidence-based 
practice.  PCP’s of Riverview felt that the evaluation tool/template was easy to access within the 
electronic medical record.  The template, when used, promotes an interdisciplinary team approach 
in the assessment, diagnosis and treatment of the child with ADHD.  When used, the tool 
provided documentation supportive of the assessment of common co-morbid conditions often 
associated with ADHD.    
 The primary focus of this clinical improvement project was to implement ADHD clinical 
practice guidelines in a family practice setting.  An evaluation tool/template was created 
embedding the DSM-V ADHD diagnostic criteria and the American Academy of Pediatrics 
clinical practice guidelines into the electronic health record to guide the primary care provider in 
the assessment, diagnosis and treatment of ADHD for children ages 4-18 in the family practice 
clinical setting.  The evaluation tool/template was created as a “smart phrase,” a software 
component of EPIC’s electronic medical record.  A “smart phrase” allows prompts and drop 
down menus, which guide the primary care provider (PCP’s) in the documentation of a 
comprehensive assessment, diagnosis, and treatment of ADHD.   
 The practice improvement project took place at Riverview Health Clinic in Crookston, 
MN.  Riverview is a rural healthcare facility located in northern Minnesota.  Family practice 
services are provided by two family practice doctors, five advanced practice nurses and two 
physician assistants.  There is also a psychologist that provides supportive mental health services 
on a weekly basis.  
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 Following the creation of the evaluation tool/template, an educational focused form was 
held for Riverview PCP’s in conjunction with Riverview’s January monthly provider meeting.  
The project director provided PCP’s an overview of the clinical practice improvement project 
including an educational module that contained a hard copy of the American Academy of 
Pediatrics Clinical Practice Guidelines and the DSM-V ADHD diagnostic criteria, along with a 
hard copy of the evaluation tool/templates with directions on accessing and using the tool.  The 
evaluation tool was launched and utilized in the PCP clinical setting for a six-week period. 
 Following the six-week study, a retrospective chart audit was performed on site by the 
project director.  Data was collected in accordance with the data collection tool. The data 
collection tool was created with inclusion of the American Academy of Pediatrics (AAP) Clinical 
Practice Guidelines (CPG) and the DSM-V ADHD diagnostic criteria.  Additionally, PCP’s were 
surveyed using a five point likert survey.  The survey questions contained criteria adopted from 
the AAP CLG and the DSM-V ADHD diagnostic criteria to assure evidence based-practice. Data 
was then analyzed using inferential statistics.     
 During the six-week study there was 81 children ages 4-18 that accessed services for 
ADHD at Riverview Clinics.  A retrospective chart audit was performed to acquire data as 
outlined in the data collection tool.  Of the 81 ADHD clinic encounters, 63% of these encounters 
documented utilization of the evaluation tool/template in the assessment, diagnosis and treatment 
of ADHD (n=51).  Documentation supporting the use of ADHD rating scales was 90% (n=46) 
with use of the evaluation tool/template and 17% (n=5) when evaluation tool/template was not 
used.  Assessment for the presence of DSM-V symptoms in more than on setting was documented 
88% with evaluation tool/template use (n=45) and 83% (n=25) in visits without its use.    
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Table L1  
EHR Documentation of ADHD Evaluation Tool/Template 
EHR Documentation ADHD Clinic Encounter 
with use of the evaluation  
tool/template (n=51) 
ADHD Clinic Encounter 
without use of evaluation 
tool/template (n=30) 
Use of ADHD Rating 
Scales 
        46/51          90%              5/30          17% 
Assessing presence of 
ADHD DSM-V symptoms 
        45/51          88%        25/30          83%          
Screening for co-morbid 
conditions 
        46/51          90%          7/30          23% 
Documentation supports an 
interdisciplinary team 
approach  
        34/51          67%          9/30          30% 
Plan of care documents 
target treatment outcomes 
        51/51         100%         28/30          93% 
Presence of written 
treatment plan with patient 
education   
        51/51         100%                30/30         100% 
Recommendation for 
appropriate follow-up 
        51/51         100%         30/30         100% 
 
 Co-morbid condition screening was documented in 90% of encounters that utilized the 
evaluation tool/template (n=46) and 23% of visits without the evaluation tool/template use (n=7).  
Documentation supporting an interdisciplinary team approach to the assessment, diagnosis, and 
treatment of ADHD was present 67% with evaluation tool/template (n=34) and 30% of visits 
without tool/template use (n=9).  
 The evaluation tool/template use provided documentation supportive of targeted treatment 
outcome 100% (n=51) while encounters without evaluation tool/template was 93% (n=28).  There 
was documentation supporting that the plan of care provided a written treatment plan and 
appropriate follow-up recommended (eg. initial assessment follow-up recommended within 2-4 
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weeks and maintenance follow-up recommended a minimum of every 3-4 months) 100% of 
encounters with or without evaluation tool/template use (n=81).   
 A five point likert scale survey was dispersed to Riverview’s 8 primary care providers 
following the six-week evaluation tool/template launching with a response rate of 75% (n=6).  
The likert scale included six questions pertaining to the evaluation tool/template (Appendix E).   
 Question one asked if the ADHD evaluation tool/template was easy to access within the 
electronic health record. There were 5 strongly agree (83.3%) and 1 agree (N=6).  Question two 
asked if the ADHD tool/template promotes an interdisciplinary team approach to the assessment, 
diagnosis, and treatment of children with ADHD.  All 6 responses strongly agreed.  Question 3 
asked if the evaluation tool/template promotes documentation of evidence-based practice.  Again, 
all 6 responded strongly agreed.   
Table L2 
 Primary Care Providers Likerts Scale Survey 
PCPs Survey Questions 1=Strongly 
Agree 
2=Agree 3=Neutral 4=Disagree 5=Strongly 
Disagree 
Tool/ template is easy 
to access in the EHR 
 
     83.3% 
 
     16.7% 
 
     0% 
 
     0% 
 
     0% 
Promotes an 
interdisciplinary team 
approach 
 
    100% 
 
     0% 
 
     0% 
 
     0% 
 
     0% 
Promotes  evidence-
based practice 
 
    100% 
 
     0% 
 
     0% 
 
     0% 
 
     0% 
Promotes screening for 
co-morbid conditions  
 
    83.3% 
 
    16.7% 
 
     0% 
 
     0% 
 
     0% 
Tool/template is 
clear/concise and 
improves workflow 
 
    66.6% 
 
    33.3% 
 
     0% 
 
     0% 
 
     0% 
PCP comfort in using 
the tool/ template  
 
    100% 
 
     0% 
 
     0% 
 
     0% 
 
     0% 
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 Question four asked if the evaluation tool/template promoted screening for common co-
morbid conditions.  Of the 6 respondents, 5 strongly agreed (83.3%) and 1 agreed.   Question five 
asked if the evaluation tool/template is clear and concise and improves work flow in the family 
practice setting.  There were 4 respondents whom strongly agreed (66.6%) and 2 agreed (33.3%).  
The final question asked if the primary care provider was comfortable in using the ADHD 
evaluation tool/template.  All 6 responded strongly agreed. 
 It is recommended that the process be implemented at Riverview Clinic.  When used, the 
ADHD Evaluation Tool/Template provided a higher level of documentation supportive of 
evidence-based practice in caring for ADHD children ages 4-18 in the primary care provider 
setting.  A post project focused forum could be planned for Riverview’s PCPs in the 
dissemination of project outcome.  The post project forum would allow for additional education 
on the ADHD evaluation tool/template and aid in further discussion.  Post project form PCPs 
feedback may result in evaluation tool/template revisions to further improve workflow and aid in 
higher use of this tool thereby promoting evidence based-practice. 
 Dissemination of project outcome could be presented via power point presentations to area 
family practice clinics.  Project outcome could also be discussed with EPIC IT representatives 
allowing them to provide the Evaluation Tool/Template to other Family Practice Clinics in which 
the contract with.  Broadening the use of this evaluation tool/template to surrounding clinics will 
further promote evidence- based practice in servicing the population of children with ADHD, 
thereby promoting optimal child outcome.    
 Limitations of this study are that it took place in a single setting with limited primary care 
providers.  The study length of duration was only six weeks.  Future research could be conducted 
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in multiple family practice settings while expanding the duration of time studied using a larger 
sample size while evaluating more PCPs.   
